Form 8-K - Current report:
SEC Accession No. 0001493152-24-041443
Filing Date
2024-10-17
Accepted
2024-10-17 17:17:59
Documents
18
Period of Report
2024-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46962
2 ex10-1.htm EX-10.1 346680
3 ex10-2.htm EX-10.2 81676
4 ex10-3.htm EX-10.3 118938
5 ex10-1_001.jpg GRAPHIC 46067
6 ex10-2_001.jpg GRAPHIC 85696
  Complete submission text file 0001493152-24-041443.txt   1042213

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE shph-20241014.xsd EX-101.SCH 3030
8 XBRL LABEL FILE shph-20241014_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE shph-20241014_pre.xml EX-101.PRE 24175
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 241378371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)